Critics say that "slop" videos made with generative AI are often repetitive or useless. But they get millions of views — and ...

An Independence-based biomedical technology company announced Thursday, Aug. 28, that it received a $2.1 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the ...

Humanoid robots are considered the most complex path. They combine a “brain,” advanced sensing, precision motion control, ...

"It's really forcing us to rethink the fundamentals of how we make sure encryption adapts to dynamic future threats," said ...

Vibe coding, or coding with AI, is growing in popularity, but engineers say you have to actually know how to code to do it well.

Colorado lawmakers earlier this week wrapped up their third consecutive special legislative session, an event that is beginning to feel less special. After meeting in August 2023 and 2024 to pass ...

In the operating room, Artisight's smart hospital platform can now autonomously detect and document patient entry and exit, procedure start and end time, and other key milestones in a patient ...

That middle class has so eroded in size and in purchasing power — and the wealth of our top earners has so exploded — that America’s most important market today is its affluent. As more companies ...

The latest example of the runaway hype that can come from such pitches is research published today by SquareX, a startup selling services for securing browsers and other client-side applications. It ...

WiseTech Global Limited ( OTCPK:WTCHF) Q4 2025 Earnings Conference Call August 26, 2025 8:00 PM ET Caroline Pham - Interim Chief Financial Officer Richard John White - Co-Founder, Executive Chairman ...

Years of Suppression and Plagiarism of a Recognized Breakthrough: It is Time for Scientists and Leaders with Integrity to Endorse Funding the Inventor and Unlock the Full Potential for Cost-Effective ...

EVM14, an off-the-shelf tumor associated antigen vaccine, has received IND approval from the U.S. FDA and acceptance from China's NMPA. The Phase I trial in the U.S. is currently underway, with first ...